About RevealDx
RevealDx is a Seattle-based healthcare AI company dedicated to dramatically improving lung cancer outcomes through advanced, radiomics and AI-enabled decision support software. Their flagship product, RevealAI-Lung, is designed to assist physicians in the non-invasive diagnosis and management of lung nodules. The software analyzes chest CT scans to produce a Malignancy Similarity Index (mSI) score, which helps radiologists make more informed follow-up recommendations and supports earlier cancer diagnosis.
RevealAI-Lung integrates directly into Picture Archiving and Communication Systems (PACS), aiming to streamline radiology workflows with a single-click operation that delivers results within seconds. The company emphasizes that its patented approach provides improved stability across image types and offers transparency in predictions by extracting local predictive value from three-dimensional analysis of lesions, combined with an analysis of the broader lung and chest. This technology has been validated in clinical trials involving over 1,500 patients from various cohorts, demonstrating improvements in radiologist performance and a reduction in false positives. RevealAI-Lung has received FDA clearance in the U.S., MDR certification in Europe, and TGA approval in Australia, and is reimbursable under Medicare in the U.S.
Focus Areas
Business Intelligence
| Key Investors | 4DMedical, Westway Capital, A-Level Capital, Alliance of Angels, Frontier Angels, Frost Data Capital, Life Science Angels |
| Partnerships | 4DMedical, Sirona, contextflow, Riverain, Fuji PACS, TriHealth |
| Acquisitions | Mindshare Medical (acquired by Precision Medical Ventures, which then became RevealDx) |
| Technology | AI-enabled software, radiomics, cloud-native (implied by software focus and integrations) |
| FDA Clearances | 1 cleared products (estimated) |
What Physicians Need to Know
For physicians, RevealDx's RevealAI-Lung offers actionable radiomic insights with a Malignancy Similarity Index (mSI) that can enhance confidence in lung nodule assessments. The system integrates directly into Picture Archiving and Communication Systems (PACS) with single-click operation, providing results within seconds and minimizing disruption to existing workflows. This can lead to more effective triage of lung nodules, earlier cancer detection, and a reduction in unnecessary procedures, ultimately improving patient care and outcomes.
RevealDx's RevealAI-Lung is designed for seamless integration into existing clinical workflows, particularly with PACS. They have established partnerships and integrations with companies like Sirona Medical, Riverain Technologies, Azra AI, and 4DMedical, allowing for enhanced lung nodule detection, characterization, and a comprehensive cardiopulmonary imaging ecosystem.
Reviews & Opinions
Videos
News, demos, and interviews about RevealDx.
Videos load interactively. If none appear, search YouTube for RevealDx →
Press & Coverage
Frequently Asked Questions
Related Companies
QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]
Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]